Results 81 to 90 of about 2,936,501 (309)

On Scalability of FDD-Based Cell-Free Massive MIMO Framework

open access: yesSensors, 2023
Cell-free massive multiple-input multiple-output (MIMO) systems have the potential of providing joint services, including joint initial access, efficient clustering of access points (APs), and pilot allocation to user equipment (UEs) over large coverage ...
Beenish Hassan, Sobia Baig, Saad Aslam
doaj   +1 more source

Experimental and computational analyses reveal that environmental restrictions shape HIV-1 spread in 3D cultures

open access: yes, 2019
Here, using an integrative experimental and computational approach, Imle et al. show how cell motility and density affect HIV cell-associated transmission in a three-dimensional tissue-like culture system of CD4+ T cells and collagen, and how different ...
Ales, J.   +14 more
core   +2 more sources

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

A lysine-free REC tag system for proximity-biotinylation applications

open access: yesScientific Reports
Protein–protein interaction analysis requires not only the detection of a single protein but also multiple interacting proteins. The proximity-dependent biotin identification (BioID) method using biotin proximity-labelled enzymes is a protein-protein ...
Soh Tokunaga   +10 more
doaj   +1 more source

Cell-Free Co-Translational Approaches for Producing Mammalian Receptors: Expanding the Cell-Free Expression Toolbox Using Nanolipoproteins

open access: yesFrontiers in Pharmacology, 2019
Membranes proteins make up more than 60% of current drug targets and account for approximately 30% or more of the cellular proteome. Access to this important class of proteins has been difficult due to their inherent insolubility and tendency to ...
Megan L. Shelby   +5 more
doaj   +1 more source

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The management of clinically apparent single lesions or oligofocal nephroblastomatosis, a facultative precursor of nephroblastoma, remains debated. Methods We retrospectively analyzed 37 patients with clinically apparent single or oligofocal nephroblastomatosis (two to three lesions per kidney) among 2347 patients registered between
Nils Welter   +17 more
wiley   +1 more source

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy. [PDF]

open access: yes, 2019
Standard methods for detecting and monitoring of IgA nephropathy (IgAN) have conventionally required kidney biopsies or suffer from poor sensitivity and specificity.
Fervenza, Fernando C   +4 more
core   +1 more source

Performance Analysis of Cell-Free Massive MIMO Systems: A Stochastic Geometry Approach [PDF]

open access: yes, 2020
© 2020 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new ...
Chatzinotas, Symeon   +4 more
core   +5 more sources

Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Pediatric central nervous system (CNS) tumors often recur despite multimodality therapy. Although re‐irradiation (re‐RT) has historically been limited by concerns for severe late toxicities, modern techniques have renewed interest in this approach. Proton therapy provides dosimetric advantages that may enable curative re‐treatment with
Jin‐Ho Song   +15 more
wiley   +1 more source

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. [PDF]

open access: yes, 2014
Erdheim-Chester disease (ECD) is a rare histiocytosis with a high prevalence of BRAF V600E mutation (>50% of patients). Patients with BRAF-mutant ECD can respond to BRAF inhibitors.
Cabrilo, Goran   +12 more
core   +3 more sources

Home - About - Disclaimer - Privacy